 Name: ___          Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  F  Service: MEDICINE  Allergies: ampicillin / Keflex / paclitaxel  Attending: ___.  Chief Complaint: Scheduled chemotherapy for Mullerian carcinoma.  Major Surgical or Invasive Procedure: None.

 History of Present Illness: The patient is a ___ year old female with stage IV high grade Mullerian Carcinoma here for chemotherapy desensitization. During her first cycle of chemotherapy, she had a reaction (SOB) without rash. Since then she has tolerated cycle ___ and 5 well on the hypersensitivity protocol. Last on ___. Restaging after 3 cycles showed improvement in R inguinal mass. Today, she presents for cycle 6. She states that she feels well and denies any fevers, chills, chest pain, shortness of breath, abdominal pain or dysuria. She does have some constipation.  Past Medical History: - ___ pt noted nontender right groin mass - ___ developed right leg swelling and presented to her PCP ___ ___ - ___ presented to her PCP; evaluation included ___ notable for 5.4 cm lesion in the right groin with flattened waveforms of the right common femoral vein, raising concern for proximal thrombus, but no DVT was detected; CT AP notable for a 4.6 x 3.3 x 3.9 cm right inguinal soft tissue mass likely representing a conglomeration of lymphadenopathy as well as right external iliac vein with central filling defect concerning for DVT. There were also several small soft tissue density nodules seen within the retroperitoneal fat and no mesenteric lymphadenopathy. Per radiology review, the pelvic organs were unremarkable, two ill-defined hypodense lesion as well as 6 mm solid right lower lobe pulmonary nodule. - ___ US guided bx groin mass: atypical epithelial cells, concerning for malignancy but was nondiagnostic given small sample size. Started on Coumadin. - ___ presented to ED for worsened ___ showed deep venous thrombosis in the right common femoral, proximal superficial femoral and deep femoral veins. CTA chest showed two segmental/subsegmental LLL pulmonary emboli. Again, 6 mm solid pulmonary nodule was seen in the RLL. She was then admitted for management of her VTE and for further evaluation of her groin mass. - ___ initial CA 125 173 - ___ MRCP showed a nonspecific 1.7 cm hepatic lesion without characteristics consistent with metastasis - ___ open biopsy of the right groin mass showed high-grade serous carcinoma of gynecologic origin - ___ discharged on therapeutic lovenox - ___ readmitted due to cellulitis at site of excisional biopsy - ___ carboplatin/paclitaxel C1D1 given with desensitization due to allergy to paclitaxel - ___ carboplatin/paclitaxel C2D1 (11R) - ___ carboplatin/paclitaxel C3D1 (11R) - ___ carboplatin/paclitaxel C4D1 - C5 carboplatin/paclitaxel given ___

PAST MEDICAL HISTORY: - ___ ___ DVT, enoxaparin - T2DM - HTN - COPD/emphysema - Anemia - Lipds - Hypothyroid - Seizure disorder, tonic clonic, last seizure ___ - One atrophic kidney - Vascular claudication - Side branch IPMN (incidentally noted on imaging) - S/P CCY ___ - Childhood kidney biopsy  Social History: ___ Family History: Denies h/o CAD, CVA, breast, ovarian, uterine, cervical or colon 

cancers. T2DM, HTN. Sister (___) with postpartum DVT/PE.

 Physical Exam: General: NAD VITAL SIGNS: T 97.7 BP 126/60 HR 78 RR 18 O2 97% RA HEENT: MMM, no OP lesions PULM: CTAB ABD: Soft, NTND, no masses or hepatosplenomegaly LIMBS: No edema, clubbing, tremors, or asterixis SKIN: No rashes or skin breakdown NEURO: Alert and oriented. No focal deficits.  Pertinent Results: ___ 06:08AM BLOOD WBC-6.4 RBC-2.74* Hgb-9.7* Hct-28.3* MCV-103* MCH-35.4* MCHC-34.3 RDW-17.8* RDWSD-68.1* Plt Ct-87* ___ 06:08AM BLOOD Glucose-196* UreaN-17 Creat-0.7 Na-138 K-4.2 Cl-103 HCO3-25 AnGap-14 ___ 06:08AM BLOOD ALT-50* AST-48* TotBili-0.3 ___ 06:08AM BLOOD Calcium-7.8* Phos-3.0 Mg-1.___ year old female with stage IV high grade Mullerian Carcinoma here for paclitaxel chemotherapy desensitization.

Stage IV Mullerian carcinoma - Recieved cycle 6 carboplatin/paclitaxel with hypersensitivity protocol and tolerated well without issue. Will follow up with her primary oncologist as an outpatient.  Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Apixaban 5 mg PO BID 2. LeVETiracetam 500 mg PO BID 3. Levothyroxine Sodium 125 mcg PO DAILY 4. Simvastatin 10 mg PO QPM 5. Ascorbic Acid ___ mg PO BID 6. Ferrous Sulfate 325 mg PO DAILY 7. Losartan Potassium 50 mg PO DAILY 8. MetFORMIN XR (Glucophage XR) 1000 mg PO BID 9. Glargine 20 Units Bedtime

 Discharge Medications: 1. Glargine 20 Units Bedtime 2. LeVETiracetam 500 mg PO BID 3. Levothyroxine Sodium 125 mcg PO DAILY 4. Ferrous Sulfate 325 mg PO DAILY 5. Ascorbic Acid ___ mg PO BID 6. Apixaban 5 mg PO BID 7. Simvastatin 10 mg PO QPM 8. MetFORMIN XR (Glucophage XR) 1000 mg PO BID 9. Losartan Potassium 50 mg PO DAILY 10. Docusate Sodium 100 mg PO BID:PRN Constipation RX *docusate sodium 100 mg 1 capsule(s) by mouth Twice a day Disp #*60 Capsule Refills:*0 11. Ondansetron 8 mg PO DAILY Duration: 2 Days RX *ondansetron 8 mg 1 tablet(s) by mouth Daily Disp #*1 Tablet Refills:*0

 Discharge Disposition: Home  Discharge Diagnosis: Mullerian Carcinoma

 Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent.

 Discharge Instructions: You were admitted for scheduled chemotherapy with carboplatin and paclitaxel. You tolerated the chemotherapy well.  Followup Instructions: ___ 